ADMINISTERING INSULIN LIKE GROWTH FACTOR I OR III TO REDUCE PERIPHERAL NEUROPATHY NOT CAUSED BY ABNORMAL INSULIN LEVELS

摘要

The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.